Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Debt Ratio: 2017-2021

Historic Debt Ratio for Sunshine Biopharma (SBFM) over the last 3 years, with Dec 2021 value amounting to 0.86.

  • Sunshine Biopharma's Debt Ratio fell 4.98% to 0.86 in Q4 2021 from the same period last year, while for Dec 2021 it was 3.29, marking a year-over-year increase of 262.34%. This contributed to the annual value of 0.86 for FY2021, which is 4.98% down from last year.
  • Latest data reveals that Sunshine Biopharma reported Debt Ratio of 0.86 as of Q4 2021, which was down 32.65% from 1.28 recorded in Q3 2021.
  • In the past 5 years, Sunshine Biopharma's Debt Ratio ranged from a high of 1.28 in Q3 2021 and a low of 0.19 during Q3 2019.
  • For the 3-year period, Sunshine Biopharma's Debt Ratio averaged around 0.72, with its median value being 0.86 (2021).
  • Per our database at Business Quant, Sunshine Biopharma's Debt Ratio tumbled by 33.50% in 2019 and then soared by 147.64% in 2021.
  • Sunshine Biopharma's Debt Ratio (Quarterly) stood at 0.31 in 2017, then decreased by 12.46% to 0.27 in 2018, then slumped by 33.50% to 0.19 in 2019, then soared by 79.18% to 0.91 in 2020, then declined by 4.98% to 0.86 in 2021.
  • Its last three reported values are 0.86 in Q4 2021, 1.28 for Q3 2021, and 1.13 during Q2 2021.